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MiR-146a Negatively Regulates TLR2-Induced
Inflammatory Responses in Keratinocytes
Florian Meisgen1, Ning Xu Lande´n1, Aoxue Wang1,2, Bence Re´thi3, Charbel Bouez4, Michela Zuccolo4,
Audrey Gueniche4, Mona Sta˚hle1, Eniko¨ Sonkoly1, Lionel Breton4 and Andor Pivarcsi1
Keratinocytes represent the first line of defense against pathogens in the skin and have important roles in
initiating and regulating inflammation during infection and autoimmunity. Here we investigated the role of miR-
146a in the regulation of the innate immune response of keratinocytes. Toll-like receptor 2 (TLR2) stimulation of
primary human keratinocytes resulted in an NF-kB- and mitogen-activated protein kinase-dependent upregula-
tion of miR-146a expression, which was surprisingly long lasting, contrasting with the rapid and transient
induction of inflammatory mediators. Overexpression of miR-146a significantly suppressed the production of IL-8,
CCL20, and tumor necrosis factor-a, which functionally suppressed the chemotactic attraction of neutrophils by
keratinocytes. Inhibition of endogenous miR-146a induced the production of inflammatory mediators even in
nonstimulated keratinocytes, and potentiated the effect of TLR2 stimulation. Transcriptomic profiling revealed
that miR-146a suppresses the expression of a large number of immune-related genes in keratinocytes. MiR-146a
downregulated interleukin-1 receptor-associated kinase 1 and TNF receptor-associated factor 6, two key adapter
molecules downstream of TLR signaling, and suppressed NF-kB promoter-binding activity as shown by promoter
luciferase experiments. Together, these data identify miR-146a as a regulatory element in keratinocyte innate
immunity, which prevents the production of inflammatory mediators under homeostatic conditions and serves as
a potent negative feedback regulator after TLR2 stimulation.
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INTRODUCTION
The skin provides a protective barrier that pathogens need to
penetrate in order to invade the organism. Keratinocytes, the
major cellular constituents of the epidermis, represent the first
line of defense against pathogens in the skin and are an
important part of the innate immune system. Upon external
stimuli, such as physical trauma, bacterial and viral infections,
or UV irradiation, keratinocytes produce numerous cytokines,
chemokines, and antimicrobial peptides. These keratinocyte-
derived inflammatory mediators serve as alarm signals for the
innate and adaptive immune system, regulate the recruitment,
activation, and retention of immune cells (neutrophils, gran-
ulocytes, dendritic cell precursors, and T cells) to the skin, and
modulate their function (Goodarzi et al., 2007; Nestle et al.,
2009). Recognition of pathogens by keratinocytes is a critical
step in the cutaneous immune response. Pattern-recognition
receptors, such as Toll-like receptors (TLRs), recognize
conserved pathogen-associated molecular patterns (Kumar
et al., 2011). Human keratinocytes express several TLRs,
including TLR2, which have important roles in the initiation
of innate immune responses in the skin (Baker et al., 2003;
Mempel et al., 2003; Pivarcsi et al., 2003; Kollisch et al.,
2005; Lebre et al., 2007). TLR2 recognizes a variety of
lipopeptides from the cell wall of Gram-positive bacteria
and yeast. Binding of specific ligands to TLR2 triggers an
intracellular signaling cascade involving MyD88, IRAKs, and
TNF receptor-associated factor 6 (TRAF6), leading to the
activation of the NF-kB and mitogen-activated protein kinase
(MAPK) pathways. This subsequently induces the expression
of cytokines, chemokines, antimicrobial peptides, and
adhesion molecules, which in turn can attract and activate
immune cells to destroy invading microbes (Pivarcsi et al.,
2004; Miller, 2008).
MicroRNAs (miRNAs) are a class of evolutionarily con-
served small noncoding RNAs that regulate gene expression
on a post-transcriptional level (Ambros, 2004; Bartel, 2004).
Key roles for miRNAs have been found in nearly all biological
processes and altered miRNA expression is associated with
diseases (Farazi et al., 2013; Fernandez-Hernando et al.,
2013). MiRNAs are key regulators of inflammatory responses
and immune regulation (Sonkoly et al., 2008; Ceribelli et al.,
2012; O’Connell et al., 2012). MiR-146a was one of the first
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miRNAs identified to be involved in innate immune responses,
being induced in macrophages upon stimulation with different
TLR ligands and inflammatory cytokines (Taganov et al.,
2006).
Much is known about pathogen recognition and the initia-
tion of innate immune response in keratinocytes (Begon et al.,
2007; Buchau et al., 2008; Kalali et al., 2008; Lee et al., 2009;
Dai et al., 2011; Niebuhr et al., 2011). However, the mech-
anisms that prevent excessive/prolonged inflammation upon
TLR activation in skin and the possible role of miRNAs in this
process are not well understood. Thus, we set out to study the
functional link between TLR2-induced miR-146a expression
and the innate immune functions of keratinocytes. Our results
identify miR-146a as a regulatory element in keratinocyte
innate immunity, which serves as a negative feedback regu-
lator after TLR2 stimulation and suppresses the production of
inflammatory mediators under homeostatic conditions.
RESULTS
MiR-146a is induced upon engagement of TLR2 in keratinocytes
Initial studies were undertaken to characterize the expression
of miR-146a in primary human keratinocytes upon TLR2
stimulation. Exposure to the TLR2 ligands zymosan and
Pam3CSK4 significantly induced miR-146a expression in
keratinocytes after 24 hours (28-fold, Po0.001 and 8-fold,
Po0.05, respectively; Figure 1a). Silencing of TLR2 by specific
small interfering RNA (siRNA; Supplementary Figure S1a
online) abolished significantly the induction of miR-146a
by zymosan (Po0.001) or Pam3CSK4 (Po0.01; Figure 1b),
demonstrating that induction of miR-146a by both zymosan
and Pam3CSK4 was TLR2 dependent.
Next, we aimed to study the regulation of miR-146a upon
zymosan treatment in more detail. Zymosan induced the
expression of IL-8, CCL20, TNF-a, and miR-146a in a time-
and concentration-dependent manner. Exposure to 100–
300mg ml 1 zymosan resulted in significant expression of
the inflammatory chemokines IL-8, CCL20, and TNF-a as well
as of miR-146a (Supplementary Figure S2 online). The induc-
tion of inflammatory mediators by zymosan was rapid and
transient: the IL-8 and CCL20 response reached its peak after
3 hours, and that of TNF-a after 1 hour (Figure 1c). MiR-146a
was strongly upregulated by zymosan at 3 hours and the
response peaked at 24 hours (Figure 1c). However, in contrast
to the transient induction of inflammatory mediators, miR-
146a expression did not return to baseline level but remained
significantly elevated at all time points studied, up to 96 hours.
The observed kinetics of miR-146a expression upon TLR2
stimulation suggested that miR-146a may be involved in
the resolution of the inflammatory response. To understand
whether the high expression of miR-146a at later time points
depends on transcriptional events or is due to the stability of
miR-146a, we measured the expression of the primary
transcript, pri-miR-146a. Interestingly, zymosan induced pri-
miR-146a only transiently at very high levels (43-fold,
Po0.001 at 3 hours), but not at later time points, in contrast
to the mature miR-146a (Figure 1c). These results suggest that
the prolonged high level of miR-146a upon zymosan stimula-
tion is mainly due to the stability of the mature miRNA.
Induction of miR-146a upon TLR2 stimulation is mediated
through the NF-jB and MAPK pathways
To explore the intracellular pathways that lead to the induction
of miR-146a upon TLR2 stimulation, we used specific chemi-
cal inhibitors that target pathways known to act downstream of
TLR2 signaling, i.e., the NF-kB and MAPK pathways. We used
inhibitors for NF-kB (BAY-11-7082), JNK (SP600125), MEK1/2
(U0126), p38 (SB203580), and we included an inhibitor for
PI3K (Wortmannin). None of these inhibitors had an effect on
the miR-146a baseline expression (Figure 1d), suggesting that
these pathways are not involved in the baseline transcription of
the miR-146a gene. Induction of miR-146a by zymosan was
reduced sevenfold (Po0.001) by pretreatment with the NF-kB
inhibitor BAY-11-7082 (Figure 1d). The MEK1/2 inhibitor
U0126 and the p38 inhibitor SB203580 also reduced zymo-
san-induced miR-146a expression to a lesser extent (2.2-fold,
Po0.01 and 2.3-fold, Po0.01, respectively), suggesting that
these MAPK pathways contribute to the induction of miR-146a.
In contrast, the JNK inhibitor SP600125 and the PI3K inhibitor
Wortmannin had no effect on zymosan-induced miR-146a
expression. These results demonstrate that zymosan-induced
miR-146a expression in keratinocytes is mediated via the NF-
kB pathway and to a lesser extent by the MEK1/2 and p38
MAPK pathways.
MiR-146a suppresses the zymosan-induced production of
inflammatory mediators in keratinocytes
To assess the functional relevance of miR-146a expression
under inflammatory conditions, we studied the effect of miR-
146a on TLR2-induced expression of selected inflammatory
mediators. To that end, we transfected primary human
keratinocytes with synthetic miR-146a or scrambled control
oligonucleotides (Supplementary Figure S1b online). Keratino-
cytes were stimulated with zymosan 48 hours after transfection
and the expression and secretion of the inflammatory media-
tors IL-8, CCL20, and TNF-a were determined 6 and 24 hours
later via quantitative real-time reverse-transcriptase–PCR and
ELISA (Figure 2a; results from unstimulated control cells are
shown in Figure 3). Overexpression of miR-146a markedly
suppressed TLR2-induced expression and production of IL-8,
CCL20, and TNF-a. To determine whether the TLR2-induced
endogenous miR-146a can act as a negative feedback in
keratinocytes, we inhibited miR-146a expression using specific
inhibitors or scrambled controls before zymosan treatment
(Figure 2b). Inhibition of endogenous miR-146a further
increased TLR2-induced expression and production of IL-8,
CCL20, and TNF-a, demonstrating that zymosan-induced miR-
146a expression acts as a negative feedback on this pathway.
MiR-146a suppresses the production of inflammatory mediators
in resting keratinocytes
To further explore the function of miR-146a in keratinocytes,
the expression of selected inflammatory mediators was also
measured in unstimulated keratinocytes upon modulation of
miR-146a expression. The messenger RNA expression and
protein secretion of IL-8, CCL20, and TNF-a were low in
resting keratinocytes; however, overexpression of miR-146a
decreased their levels even further (Figure 3a, Supplementary
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Figure S3 online), with the exception of TNF-a, which could
not be detected in supernatants of unstimulated keratinocytes.
Next, we aimed at exploring the function of homeostatic miR-
146a expression in resting keratinocytes. Surprisingly, inhibi-
tion of the relatively low-expressed endogenous miR-146a in
unstimulated keratinocytes markedly increased expression and
release of IL-8, CCL20, and TNF-a (Figure 3b, Supplementary
Figure S3 online). These results imply that endogenous
miR-146a has a role in the suppression of inflammatory
mediators in keratinocytes in the absence of pathogens.
Overexpression of miR-146a induces profound changes in the
transcriptome of keratinocytes
Next, we aimed to explore the effect of miR-146a on the
transcriptome of keratinocytes. Global transcriptome analysis
using Affymetrix array identified 433 genes whose levels were
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Figure 1. TLR2 ligands induce miR-146a, involving the TLR2, NF-jB, and MAPK pathways. (a) Primary human keratinocytes were treated with zymosan or
Pam3CSK4. Total RNA was collected 24 hours later and miR-146a expression level was determined by qRT–PCR. (b) Keratinocytes were transfected with TLR2-
specific siRNA and subsequently treated with zymosan or Pam3CSK4. MiR-146a expression was measured after 24 hours. (c) Keratinocytes were exposed to
100mg ml 1 zymosan and expression kinetics of IL-8, CCL20, TNF-a, miR-146a, and pri-miR-146a were determined using qRT–PCR. (d) Keratinocytes were
treated with chemical inhibitors for NF-kB (BAY-11-7082), JNK (SP600125), MEK1/2 (U0126), p38 (SB203580), or PI3K (Wortmannin) and were exposed to
zymosan 1 hour later. MiR-146a expression after 24 hours was compared with that of DMSO-treated control cells. All results are representative of three
independent experiments, each performed in triplicate. MAPK, mitogen-activated protein kinase; qRT–PCR, quantitative real-time reverse-transcriptase–PCR; TLR,
Toll-like receptor. *Po0.05; **Po0.01; ***Po0.001.
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significantly regulated by overexpression of miR-146a in
keratinocytes (Supplementary Table S1 online). In addition
to IL-8, CCL20 and TNF-a, many other chemokines, cytokines,
antimicrobial peptides, and growth factors were regulated by
miR-146a. To gain insights into the role of miR-146a in
keratinocytes, we searched for over-representation of func-
tional categories among miR-146a-regulated genes. Func-
tional annotation of miR-146a-regulated genes revealed that
genes involved in biological processes such as ‘‘immune
response’’, ‘‘inflammation’’, ‘‘host defense’’, or ‘‘chemotaxis’’
were highly enriched among miR-146a-regulated genes,
suggesting that miR-146a preferentially regulates these biolo-
gical and molecular processes (Figure 4a). Classification
according to molecular function showed that genes classified
as cytokines, chemokines, or membrane channel proteins
were significantly enriched (Figure 4b). Interestingly, classifi-
cation of the regulated genes according to their location in
subcellular structures revealed that secreted proteins and
membrane proteins were highly enriched (Figure 4c), suggest-
ing that miR-146a preferentially regulates genes involved in
cell–cell communication. These findings demonstrate that
miR-146a has a profound effect on the transcriptome and
regulates a large number of genes involved in the immune
function of keratinocytes: among them are cytokines (e.g., IL-
1b, IL-6, IL-17F, IL-23A, TNF-a), chemokines (e.g., CCL5,
CCL20, CXCL1, CXCL2, CXCL10, CXCL11, IL-8), antimicro-
bial peptides (e.g., DEFA5, DEFB4A, DEFB113), and HLA
genes (e.g., HLA-DPA1, -DQA1, -DQA2) (Figure 4d).
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Figure 2. MiR-146a suppresses the TLR2-induced production of IL-8, CCL20, and TNF-a in keratinocytes. Keratinocytes were transfected with (a) miR-146a
precursor (pre-miR-146a) or scrambled control precursor (pre-miR-Ctrl); (b) miR-146a inhibitor (anti-miR-146a) or scrambled control inhibitor (anti-miR-Ctrl). After
48 hours, cells were exposed to 100mg ml1 zymosan. The expression and secretion of IL-8, CCL20, and TNF-a were determined 6 and 24 hours later using qRT–
PCR and ELISA, respectively. qRT–PCR, quantitative real-time reverse-transcriptase–PCR; TLR, Toll-like receptor; TNF, tumor necrosis factor; *Po0.05; **Po0.01;
***Po0.001.
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MiR-146a suppresses NF-jB-dependent promoter-binding
activity in keratinocytes
The induction of an inflammatory response upon TLR stimula-
tion in keratinocytes is mainly mediated via the NF-kB
signaling pathway (Kollisch et al., 2005). Therefore, we
tested whether miR-146a influences the expression of NF-
kB-related genes. Gene set enrichment analysis of the
transcriptome-wide profiling revealed significant enrichment
of NF-kB target genes among genes suppressed by miR-146a
(Figure 4e), suggesting that this pathway is preferentially
targeted by miR-146a in keratinocytes. Next, we aimed to
determine whether miR-146a has a direct effect on NF-kB
activation. To that end, we transfected keratinocytes with an
NF-kB luciferase reporter. Measurement of luciferase activity
upon zymosan stimulation revealed a 13-fold increase in the
NF-kB-dependent DNA-binding activity, in accordance with
previous reports (Olaru and Jensen, 2010). Overexpression
of miR-146a significantly suppressed zymosan-induced
NF-kB activity (0.57-fold, Po0.05), indicating that miR-146a
can suppress the NF-kB signal transduction pathway in
keratinocytes. This contention was supported by the effect of
miR-146a inhibitors, which resulted in further elevated
zymosan-induced NF-kB activity (1.79-fold, Po0.01)
(Figure 4f). Altogether, these data imply that zymosan-induced
miR-146a expression is an effective suppressor of NF-kB
activity in keratinocytes.
MiR-146a represses the attraction of neutrophils
To investigate the functional implication of this massive
change of gene expression in keratinocytes upon miR-146a
modulation, we tested the chemotactic potential of keratino-
cytes to attract neutrophil granulocytes. To that end, we let
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primary neutrophils migrate toward the supernatant of kerati-
nocytes that overexpressed or were inhibited for miR-146a in
a Boyden chamber. Counting of the migrated neutrophils
showed that miR-146a overexpression in keratinocytes sig-
nificantly reduced chemotactic migration (0.54-fold, Po0.05),
whereas miR-146a inhibition led to a strong increase in
neutrophil attraction (5.87-fold, Po0.05; Figure 4g). These
results clearly demonstrate the functional relevance of miR-
146a expression in keratinocytes.
MiR-146a suppresses IRAK1 and TRAF6 expression in
keratinocytes
Interleukin-1 receptor-associated kinase 1 (IRAK1) and TRAF6
have been identified as direct targets of miR-146a in macro-
phages (Taganov et al., 2006); however, they are not targeted
by miR-146a in lung epithelial cells (Perry et al., 2008). As
IRAK1 and TRAF6 are important parts of the signaling cascade
between TLRs and the NF-kB pathway (Takeda and Akira,
2004), we hypothesized that the observed effect of miR-146a
could be mediated by repression of IRAK1 and TRAF6 in
keratinocytes. We found that overexpression of miR-146a
significantly suppressed IRAK1 and TRAF6 expression in
keratinocytes, both at the messenger RNA and the protein
level, whereas miR-146a inhibition led to an increased
expression of IRAK1 and TRAF6 (Figure 5a and b). These
results suggest that miR-146a can reduce the activity of the
TLR/NF-kB pathway in keratinocytes by downregulating
IRAK1 and TRAF6. To confirm the importance of IRAK1 in
the miR-146a-mediated regulation of TLR signaling, we
knocked down IRAK1 using siRNA (Supplementary Figure
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Figure 4. MiR-146a suppresses the expression of inflammatory mediators in keratinocytes by inhibition of NF-jB activation and represses neutrophil
chemotaxis. Global transcriptome profiling was performed in independent biological triplicates for primary human keratinocytes transfected with either miR-146a
precursor (pre-miR-146a) or scrambled control precursor (pre-miR-Ctrl). (a–c) Significantly regulated genes were categorized according to their biological or
molecular function or their cellular location, using GO terms. The most highly enriched categories are shown. (d) Selected deregulated genes involved in
inflammation are displayed as a heat map, green indicating low expression, red indicating high expression. Cytokines are labeled in magenta, chemokines in
green, defensins in blue, and HLA genes in purple. (e) Genes represented in the profile data set were ranked by fold change (pre-miR-146a/pre-miR-Ctrl). GSEA
evaluated enrichment within the profile data set for the reported target genes of the NF-kB signaling pathway. Vertical bars along the x-axis of the GSEA plot
denote the positions of the NF-kB target genes within the ranked list. (f) Keratinocytes were co-transfected with an NF-kB luciferase reporter plasmid and miR-146a
precursor/inhibitor or regarding controls for 48 hours, exposed to medium or 100mg ml 1 zymosan, and luciferase activity was measured after 6 hours.
(g) Keratinocytes were transfected with miR-146a precursor/inhibitor or regarding controls for 48 hours. The keratinocyte supernatant was used to attract
primary neutrophils in a Boyden chamber and counted using flow cytometry. Plots showing forward/side scatter and quantification of migrated neutrophils.
GO, Gene Ontology; GSEA, gene set enrichment analysis; NES, normalized enrichment score; *Po0.05; **Po0.01.
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S1c–d online) in the presence or absence of miR-146a
inhibitors. Although baseline expression of IL-8 was unaffected
by IRAK1 knockdown, zymosan-induced IL-8 expression was
abolished in keratinocytes in which both miR-146a and IRAK1
were depleted, confirming the importance of IRAK1 as a
mediator of the effect of miR-146a during inflammatory
responses in primary human keratinocytes (Figure 5c).
DISCUSSION
Skin is frequently in contact with a variety of microorganisms,
and keratinocytes are the first line of defense within skin that
sense the ‘‘danger’’ signals, among others, via TLRs. Impaired
balance between the appropriate inflammatory response and
the timely shutdown may lead to the development of inflam-
matory skin diseases (Lai and Gallo, 2008). In this study, we
identify miR-146a as a potent negative regulator of the innate
immune response in keratinocytes.
The rapid and high induction of miR-146a in keratinocytes
upon encounter with TLR2 ligands is analogous to miR-146a
induction by TLR ligands in immune cells (Jurkin et al., 2010;
Boldin et al., 2011; El Gazzar et al., 2011; Quinn et al., 2013)
as well as in some nonimmune cell types such as microglial
cells (Saba et al., 2012) and intestinal epithelial cells (Chassin
et al., 2012), supporting a role for miR-146a as a general
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Figure 5. MiR-146a downregulates IRAK1 and TRAF6 in keratinocytes. Keratinocytes were transfected with miR-146a precursor (pre-miR-146a), scrambled
control precursor (pre-miR-Ctrl), miR-146a inhibitor (anti-miR-146a), or scrambled control inhibitor (anti-miR-Ctrl) for 72 hours, and the expression of IRAK1
mRNA and protein was determined by (a) qRT–PCR and (b) western blotting, respectively. Densitometry quantification is normalized to actin. (c) Keratinocytes
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regulator of the innate immune response. We show that, in
addition to NF-kB, MEK1/2 and p38 are also involved in the
TLR2-dependent induction of miR-146a in keratinocytes,
suggesting a more complex and fine-tuned regulation of
miR-146a besides the acute inflammatory NF-kB pathway.
This is in agreement with the fact that TLR2 signaling primarily
proceeds through the NF-kB pathway, and in addition through
three different MAPK pathways (JNK, Erk1/2, and p38; Deva
et al., 2003; Into et al., 2004). MiR-146a expression has been
shown to be regulated through the activation of the NF-kB
pathway in other cell types (Taganov et al., 2006; Bhaumik
et al., 2008; Perry et al., 2009; Curtale et al., 2010).
Interestingly, in alveolar epithelial cells miR-146a is induced
via NF-kB and JNK, but not via MEK1/2 or p38 (Perry et al.,
2009), indicating that the regulation of miR-146a expression
may partly be cell-type dependent.
In agreement with earlier reports (Kawai et al., 2002;
Pivarcsi et al., 2003; Kollisch et al., 2005), inflammatory
mediators and host defense genes (IL-8, CCL20, and TNF-a)
were transiently induced upon TLR2 engagement in
keratinocytes as a part of keratinocyte host defense
response. In contrast, miR-146a remained elevated for at
least 4 days following TLR2 stimulation in keratinocytes. This
prolonged high level of miR-146a in keratinocytes upon
zymosan treatment may be mainly due to the stability of
mature miR-146a rather than sustained transcriptional
upregulation, as we found that the primary transcript of
miR-146a was not significantly upregulated after 24 hours.
Although the precise mechanisms of miRNA decay are yet
unknown, the half-life of miRNAs in cells can be several days
long (Bail et al., 2010; Gantier et al., 2011).
MiR-146a strongly suppressed the zymosan-induced expres-
sion of IL-8, CCL20, and TNF-a in keratinocytes. Importantly,
not only ectopic overexpression of miR-146a but also zymo-
san-induced endogenous miR-146a at physiological concen-
trations can efficiently suppress these mediators, as evidenced
by the marked enhancement of zymosan-induced release of
inflammatory mediators upon inhibition of miR-146a. These
findings demonstrate that miR-146a regulates the acute
inflammatory response of keratinocytes upon TLR2 engage-
ment. Strikingly, miR-146a had a profound effect on a vast
variety of inflammatory genes: among them are the three
major neutrophil-attracting chemokines, IL-8, CXCL1, and
CXCL2. In accordance with this, we demonstrated a negative
effect of miR-146a on the neutrophil-attracting capacity of
keratinocytes. The relative contribution of IL-8, CXCL1,
CXCL2, and maybe other chemokines on this effect remains
to be investigated.
Interestingly, inhibition of endogenous miR-146a led to
markedly enhanced expression and secretion of inflammatory
mediators even in the absence of stimulation, indicating that
physiological concentrations of miR-146a in resting keratino-
cytes have a profound effect on the production of inflamma-
tory mediators. This implies that loss/downregulation of
miR-146a may lead to autoinflammatory/autoimmune condi-
tions. Indeed, targeted deletion of miR-146a leads to an
autoimmune phenotype and exaggerated inflammatory response
in mice (Boldin et al., 2011; Yang et al., 2012). Surprisingly,
even mice overexpressing miR-146a develop spontaneous
signs of autoimmunity (Guo et al., 2013), highlighting
the complex role of miR-146a in the regulation of
inflammation and autoimmunity in vivo. In psoriasis, a
chronic inflammatory skin disease, a strong immune
response in the skin is provoked, although no danger signals
are present. Interestingly, miR-146a is overexpressed in
psoriasis skin, suggesting that it cannot fully compensate for
the deregulated immune response of keratinocytes (Sonkoly
et al., 2007). Thus, deregulation of miR-146a expression may
have a role in inflammatory skin diseases. Recently, it has
been shown that TLR2 signaling can suppress the TLR3
pathway (Lai et al., 2009); thus, overexpression of miR-146a
may contribute to skin inflammation by enhancing TLR3
signaling. Further studies are needed to appreciate the role
of miR-146a in psoriasis and other inflammatory skin diseases.
Our data demonstrate that miR-146a suppresses the NF-kB
promoter-binding activity in keratinocytes. Accordingly, over-
expression of miR-146a led to the downregulation of a large
number of mediators of key importance of the innate immune
function in keratinocytes, such as chemokines, cytokines,
antimicrobial peptides, and signaling molecules and receptors.
In addition to IL-8, other chemokines such as CCL5, CXCL10,
and CXCL11 were downregulated, suggesting that miR-146a
may regulate the recruitment of several immune cell types to
the skin upon injuries or infections. Moreover, we show that
miR-146a downregulates IRAK1 and TRAF6 in keratinocytes,
two previously identified bona fide targets of miR-146a. Our
results thus suggest a model in which miR-146a suppresses
NF-kB activity and inflammation through the targeting of
IRAK1 and TRAF6 (Figure 5d).
In conclusion, we have identified a previously unrecognized
regulatory mechanism in keratinocyte innate immunity, in
which TLR2-ligand-induced miR-146a acts as a negative feed-
back regulator of inflammation through downregulation of the
IRAK1/TRAF6/NF-kB pathway. Thus, miR-146a may contribute
to the resolution of inflammation by shutting down excess
inflammatory responses in keratinocytes exposed to microbial
agents, whereas under homeostatic conditions it may function
by setting the threshold of the response to external stimuli, thus
preventing autoimmunity in the absence of pathogens.
MATERIALS AND METHODS
Cell culture
Normal human adult epidermal keratinocytes were purchased from
Life Technologies (Carlsbad, CA) and cultured in EpiLife serum-free
medium including human keratinocyte growth supplement and
100 U ml 1 penicillin/streptomycin at 37 1C in 5% CO2. Human
keratinocyte growth supplement was removed 1 day before treatment
or transfection in order to avoid disturbance by the presence of
hydrocortisone. Keratinocytes were treated with zymosan
(100mg ml 1) or Pam3CSK4 (50mg ml
 1) (Invivogen, Toulouse,
France). For inhibiting signaling pathways, keratinocytes were treated
with BAY-11-7082, SB203580, U0126 (Merck, Darmstadt, Germany),
or SP600125 (Santa Cruz Biotechnology, Santa Cruz, CA) at 10mM or
Wortmannin (Merck) at 1mM concentration. After 1 hour, medium or
zymosan was added and cells were collected 24 hours later. To study
the biological effects of miR-146a on keratinocytes, third passage
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keratinocytes at 50–60% confluence were transfected using Lipofec-
tamine 2000 (Life Technologies) with 1 nM pre-miR miR-146a
precursor or negative control #1 (Life Technologies); 50 nM miRCURY
LNA miRNA Power inhibitor for hsa-miR-146a or negative control A
(Exiqon, Vedbaek, Denmark); 10 nM Silencer select siRNA for TLR2 or
siRNA negative control #1; 160 nM siRNA for IRAK1 or siRNA
negative control (Life Technologies). Efficiency of the transfections
was determined by quantitative real-time reverse-transcriptase –PCR
(Supplementary Figure S1 online).
RNA extraction and quantitative real-time PCR
Total RNA was extracted using Trizol (Life Technologies) or the
miRNeasy Mini kit (Qiagen, Hilden, Germany). Quantification of
miR-146a was performed using TaqMan Real-Time PCR (Life Tech-
nologies) according to the manufacturer’s protocols and normalized
toward U48 RNA using DCt calculation. To quantify messenger RNAs,
total RNA was reverse transcribed using the RevertAid First Strand
cDNA Synthesis Kit (Fermentas, Pittsburgh, PA). TLR2, CCL20, IRAK1,
TRAF6, and pri-miR-146a were quantified by TaqMan gene expression
assays (Life Technologies); IL-8 and TNF-a were quantified using
specific primers and probes (IL-8 fwd: 50-CCACACTGCGCCAACA-30;
rev: 50-GCATCTTCACTGATTCTTGGAT-30; probe: 50-CTGGGTGCA
GAGGGTTGTGG-30; TNF-a fwd: 50-TCTTCTCGAACCCCGAGTGA-
30; rev: 50-CCTCTGATGGCACCACCAG-30; probe: 50-TAGCC
CATGTTGTAGCAAACCCTCAAGCT-30). Gene expression was nor-
malized on the basis of 18S RNA (18S fwd: 50-CGGCTACCACATC
CAAGGAA-30; rev: 50-GCTGGAATTACCGCGGCT-30, probe: 50-TGC
TGGCACCAGACTTGCCCTC-30). Gene expression profiling was per-
formed using the Affymetrix GeneTitan ST1.2 platform. Gene Ontology
(Huang da et al., 2009) and gene set enrichment analysis (Subramanian
et al., 2005) analyses were performed as previously described.
Neutrophil chemotaxis assay
Primary human neutrophils were isolated from 0.2% EDTA-antic-
oagulated whole blood collected by venipuncture from healthy
donors. Erythrocytes were removed using dextran sedimentation
(2:1 mixture of blood:6% dextran/0.9% NaCl), followed by hypotonic
lysis using double-distilled H2O. Purified leukocytes were suspended
in EpiLife serum-free keratinocyte growth medium, and 6 105 cells
were added to the inner chamber of a 3-mm polyethylene tereph-
thalate membrane cell culture insert (BD Falcon, Erembodegem,
Belgium). The outer chamber contained culture medium from
keratinocytes transfected with pre-miR-146a, pre-miR-Ctrl, anti-miR-
146a, or anti-miR-Ctrl. After incubation for 1.5 hours at 37 1C in 5%
CO2, the migrated neutrophils in the outer chamber were quantified
by flow cytometry, normalizing the culture medium volume by
addition of CountBright counting beads (Life Technologies).
Protein detection and luciferase assays are described in
Supplementary Information online.
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